Mission & Vision
Human beings are still not equal facing access to appropriate healthcare and medical treatments. Medical needs remain unmet in some areas of the globe.
High quality standards in drug research and development is a must-have so that any human being around the world benefits from adequate medications and healthcare.
Various reasons lead pharmaceutical companies to globalize drug development such as improvement of patient health and access to innovative treatments worldwide, reduction of costs and timelines to conduct clinical trials and launch medicinal products onto the market.
North America and Europe remain the key and traditional geographic areas for multinational clinical trials. Over the last decade, emerging countries have increasingly been included in global clinical trials. Resources and medical infrastructures may be challenging in some regions, nonetheless they become a growing market for global drug development.
Lawson ClinExell is very committed to globalization of clinical research delivering adapted and solution-driven services in various aspects of study management to lead our clients to successful innovative projects.
Please follow the link to learn more about Lawson ClinExell services.
After over 14 years of experience in pharmaceutical industry and 10 years in clinical trial management in academy and various companies such as Actelion (A Janssen pharmaceutical company of Johnson & Johnson), INC Research (for Bayer and Pfizer), Swiss Tropical and Public Health Institute, Vectura, Sibi Rébecca Lawson founded Lawson ClinExell to be an active and major partner for global health improvement.
She holds a Bachelor of Science in Biochemistry, with a specialization in chemistry applied to pharmaceutical industry and a Master of Science in Skin Biology and Pharmacology, both from University of Paris VII Denis Diderot. Her M. Sc. research project was awarded by Pierre Fabre Laboratories “PRIX DUCRAY RECHERCHE” in 2001.
She is native French speaker and also fluent in English.
Sibi has a solid expertise in global clinical trial management as a CRA/lead CRA and trial manager, which results in successful initiation and execution of global phase I-III clinical trials across North America, LATAM, Europe and AAP.
This professional achievement includes leading on-site monitoring activities, coordinating regulatory and GCP compliance, managing external providers in several therapeutics areas (Respiratory Diseases, Ophthalmology, Infectious diseases, Pediatrics, Vaccines).
Sibi will deliver her clients quality and customized services with high professionalism and efficiency through:
Our company draws its business strength to achieve successful partnerships from the following core values:
Ethics | Trust | Empowerment | Equity
These driving forces are placed in the heart of Lawson ClinExell’s mandate which lead to a strong commitment to offering quality services including a full understanding of clients business objectives to bring an active support in each step of their projects implementation.